Fabino Enterprises share price
BSE: 543444Pharmaceuticals & Biotechnology
Last traded ₹20.31 on 27 Apr 2026
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Sep 2026
29 Sep · Board meeting
Meeting on 29 Sep 2026
Results
Standalone, as consolidated accounts are on record for only 3 of the last ten years; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 23 May
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹11 Crup 1,480.82%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹0.11 CrHalf year to Sep 2025: −₹0.25 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −1.0%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
| ₹ crore | Sep 2022Filed 22 Nov | Mar 2023Filed 30 May | Sep 2023Filed 2 Dec | Mar 2024Filed 2 Aug | Sep 2024Filed 12 Nov | Mar 2025Filed 29 May | Sep 2025Filed 14 Nov | Mar 2026Filed 23 May |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.0 | 2.3 | 0.9 | 5.1 | 4.3 | 13.8 | 0.7 | 10.7 |
| Net profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | −0.2 | −0.1 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 0.9% | 0.1% | 4.9% | 0.0% | 1.1% | 0.6% | −36.6% | −1.0% |
Business segments
In the year to Mar 2026 the company reports one business segment, Pharmaceuticals, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −38.0% | – | – | 0.0% |
Fabino Enterprises share price by year
Each calendar year to 2025.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 15.70 | −52.3% | 35.64 | 15.70 |
| 2024 | 32.90 | +19.6% | 43.84 | 23.55 |
| 2023 | 27.50 | −14.1% | 35.20 | 26.75 |
| 2022 | 32.00 | – | 46.65 | 23.50 |
Recent sessions
The last 10 trading days to 27 Apr 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Apr 2026 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 | 18,000 |
| 9 Apr 2026 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 1,74,000 |
| 8 Apr 2026 | 18.43 | 18.43 | 18.43 | 18.43 | 18.43 | 3,000 |
| 7 Apr 2026 | 17.56 | 17.56 | 17.56 | 17.56 | 17.56 | 3,000 |
| 2 Apr 2026 | 16.70 | 16.73 | 16.70 | 16.73 | 16.71 | 9,000 |
| 1 Apr 2026 | 15.94 | 15.94 | 15.94 | 15.94 | 15.94 | 6,000 |
| 30 Mar 2026 | 14.70 | 15.43 | 14.70 | 15.19 | 15.19 | 9,000 |
| 24 Mar 2026 | 13.40 | 14.70 | 13.40 | 14.70 | 13.51 | 36,000 |
| 20 Mar 2026 | 13.80 | 14.00 | 13.80 | 14.00 | 13.89 | 75,000 |
| 6 Mar 2026 | 13.75 | 13.75 | 13.75 | 13.75 | 13.75 | 6,000 |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 16 Dec 2025 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
Company details
- Legal name
- FABINO ENTERPRISES LIMITED
- BSE code
- 543444
- ISIN
- INE0DRT01018
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Jan 2022
- Face value
- ₹10
- CIN
- L24100DL2011PLC226781
- Corporate identity number, the registrar of companies' code for it